Investing With IBD cover image

Ep 177: Ross Haber: Trusting The Follow-Through Day

Investing With IBD

CHAPTER

The Fundamentals of a Biotech Position

The company has a 24% EPS growth rate with an earnings stability of three, you know, so meaning very stable earnings. Is the fundamentals coming into this picture at all, or are you just really kind of focused on the technical? Oh, no, the fun. I mean, that wouldn't get the fun. It wouldn't make it on my top 10 as well if it wasn't for the fundamentals. That's what gives me confidence to hold a position in anything.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner